242 related articles for article (PubMed ID: 8292312)
21. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
22. The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine.
Curtis AR; Richards RW
Ann Clin Psychiatry; 2007; 19(3):199-200. PubMed ID: 17729023
[No Abstract] [Full Text] [Related]
23. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
Volk S
Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
[No Abstract] [Full Text] [Related]
24. [Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study].
Hantouche EG; Bouhassira M; Lancrenon S
Encephale; 2000; 26(6):73-83. PubMed ID: 11217541
[TBL] [Abstract][Full Text] [Related]
25. Drug response assessed by the Modified Maudsley Obsessive-Compulsive Inventory.
Dominguez RA; Jacobson AF; de la Gandara J; Goldstein BJ; Steinbook RM
Psychopharmacol Bull; 1989; 25(2):215-8. PubMed ID: 2602515
[No Abstract] [Full Text] [Related]
26. Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities.
Garber HJ; McGonigle JJ; Slomka GT; Monteverde E
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1157-60. PubMed ID: 1429420
[TBL] [Abstract][Full Text] [Related]
27. A double-blind trial of fluoxetine in pathologic skin picking.
Simeon D; Stein DJ; Gross S; Islam N; Schmeidler J; Hollander E
J Clin Psychiatry; 1997 Aug; 58(8):341-7. PubMed ID: 9515971
[TBL] [Abstract][Full Text] [Related]
28. In-patient treatment for resistant obsessive-compulsive disorder.
Al-Sughayir MA
Saudi Med J; 2000 Feb; 21(2):193-5. PubMed ID: 11533781
[TBL] [Abstract][Full Text] [Related]
29. Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors.
Sasso DA; Kalanithi PS; Trueblood KV; Pittenger C; Kelmendi B; Wayslink S; Malison RT; Krystal JH; Coric V
J Clin Psychopharmacol; 2006 Dec; 26(6):685-7. PubMed ID: 17110840
[No Abstract] [Full Text] [Related]
30. Pharmacologic treatment of severe skin-picking behaviors in Prader-Willi syndrome. Two case reports.
Warnock JK; Kestenbaum T
Arch Dermatol; 1992 Dec; 128(12):1623-5. PubMed ID: 1456757
[TBL] [Abstract][Full Text] [Related]
31. Clinical effects of naltrexone on autistic behavior.
Zingarelli G; Ellman G; Hom A; Wymore M; Heidorn S; Chicz-DeMet A
Am J Ment Retard; 1992 Jul; 97(1):57-63. PubMed ID: 1497864
[TBL] [Abstract][Full Text] [Related]
32. Self-injurious behavior and serotonin in Prader-Willi syndrome.
Hellings JA; Warnock JK
Psychopharmacol Bull; 1994; 30(2):245-50. PubMed ID: 7831463
[TBL] [Abstract][Full Text] [Related]
33. Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation.
Koran LM; Gamel NN; Choung HW; Smith EH; Aboujaoude EN
J Clin Psychiatry; 2005 Apr; 66(4):515-20. PubMed ID: 15816795
[TBL] [Abstract][Full Text] [Related]
34. The dexamethasone suppression test as an indication of depression in patients with mental retardation.
Mattes JA; Amsell L
Am J Ment Retard; 1993 Nov; 98(3):354-9. PubMed ID: 7904820
[TBL] [Abstract][Full Text] [Related]
35. Lack of efficacy of low doses of quetiapine addition in refractory obsessive-compulsive disorder.
Sevincok L; Topuz A
J Clin Psychopharmacol; 2003 Oct; 23(5):448-50. PubMed ID: 14520120
[TBL] [Abstract][Full Text] [Related]
36. [Personality disorders and obsessive-compulsive disorder: critical analysis of the literature data and our studies].
Bellino S; Barzega G; Bogetto F; Maina G; Ravizza L
Minerva Psichiatr; 1995 Mar; 36(1):47-50. PubMed ID: 7643732
[No Abstract] [Full Text] [Related]
37. Successful fluoxetine treatment of pathologic jealousy.
Lane RD
J Clin Psychiatry; 1990 Aug; 51(8):345-6. PubMed ID: 2380161
[TBL] [Abstract][Full Text] [Related]
38. Blink rate as an index of dopamine function in adults with mental retardation and repetitive behavior disorders.
Bodfish JW; Powell SB; Golden RN; Lewis MH
Am J Ment Retard; 1995 Jan; 99(4):335-44. PubMed ID: 7695876
[TBL] [Abstract][Full Text] [Related]
39. Fluoxetine in the treatment of obsessive compulsive disorder.
Fontaine R; Chouinard G
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):605-8. PubMed ID: 3878975
[TBL] [Abstract][Full Text] [Related]
40. Relationships between psychiatric conditions and behavior problems among adults with mental retardation.
Rojahn J; Matson JL; Naglieri JA; Mayville E
Am J Ment Retard; 2004 Jan; 109(1):21-33. PubMed ID: 14651452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
